These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 29601337)

  • 1. Future of Liquid Biopsies With Growing Technological and Bioinformatics Studies: Opportunities and Challenges in Discovering Tumor Heterogeneity With Single-Cell Level Analysis.
    Ramalingam N; Jeffrey SS
    Cancer J; 2018; 24(2):104-108. PubMed ID: 29601337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsy: General Concepts.
    Poulet G; Massias J; Taly V
    Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
    Junqueira-Neto S; Batista IA; Costa JL; Melo SA
    Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Biopsy: Current Status and Future Perspectives.
    Mader S; Pantel K
    Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-educated platelets.
    In 't Veld SGJG; Wurdinger T
    Blood; 2019 May; 133(22):2359-2364. PubMed ID: 30833413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.
    Russano M; Napolitano A; Ribelli G; Iuliani M; Simonetti S; Citarella F; Pantano F; Dell'Aquila E; Anesi C; Silvestris N; Argentiero A; Solimando AG; Vincenzi B; Tonini G; Santini D
    J Exp Clin Cancer Res; 2020 May; 39(1):95. PubMed ID: 32460897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfluidic-based technologies in cancer liquid biopsy: Unveiling the role of horizontal gene transfer (HGT) materials.
    Haghjooy Javanmard S; Rafiee L; Bahri Najafi M; Khorsandi D; Hasan A; Vaseghi G; Makvandi P
    Environ Res; 2023 Dec; 238(Pt 1):117083. PubMed ID: 37690629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics.
    Geeurickx E; Hendrix A
    Mol Aspects Med; 2020 Apr; 72():100828. PubMed ID: 31711714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis.
    De Rubis G; Rajeev Krishnan S; Bebawy M
    Trends Pharmacol Sci; 2019 Mar; 40(3):172-186. PubMed ID: 30736982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles.
    Corvigno S; Johnson AM; Wong KK; Cho MS; Afshar-Kharghan V; Menter DG; Sood AK
    Mol Cancer Ther; 2022 Jul; 21(7):1067-1075. PubMed ID: 35545008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced liquid biopsy technologies for circulating biomarker detection.
    Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
    J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of circulating biomarkers in liquid biopsy diagnostics.
    Yeo JC; Lim CT
    Biotechniques; 2018 Oct; 65(4):187-189. PubMed ID: 30284936
    [No Abstract]   [Full Text] [Related]  

  • 16. Refining Cancer Management Using Integrated Liquid Biopsy.
    Qiu J; Xu J; Zhang K; Gu W; Nie L; Wang G; Luo Y
    Theranostics; 2020; 10(5):2374-2384. PubMed ID: 32089746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid Biopsy, the hype vs. hope in molecular and clinical oncology.
    Mohanty A; Mohanty SK; Rout S; Pani C
    Semin Oncol; 2021 Jun; 48(3):259-267. PubMed ID: 34384614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing Liquid Biopsies in Clinical Trials: State of Affairs, Opportunities, and Challenges.
    Lustberg MB; Stover DG; Chalmers JJ
    Cancer J; 2018; 24(2):61-64. PubMed ID: 29601331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics Analysis for Cell-Free Tumor DNA Sequencing Data.
    Chen S; Liu M; Zhou Y
    Methods Mol Biol; 2018; 1754():67-95. PubMed ID: 29536438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.